• Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

    Recruiting

    3 1 1 1
    France Germany Greece Italy Poland Portugal +1
  • A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

    Recruiting

    3 1
    Investigated diseases:
    Belgium Czechia Denmark France Germany Italy +2
  • A Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia

    Recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Finland France Germany Italy +4
  • Testing bifikafusp alfa, onfekafusp alfa, and pembrolizumab combination in patients with advanced melanoma that did not respond to previous immunotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany Italy
  • A study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Norway Spain
  • A study testing etentamig alone or with drug combinations in adult patients with multiple myeloma to assess safety and changes in disease activity

    Recruiting

    1 1 1 1
    Investigated diseases:
    Norway
  • A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

    Recruiting

    2 1
    Czechia France Germany Italy Poland Portugal +1
  • Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

    Recruiting

    2 1 1 1
    Czechia Denmark France Germany Italy Spain
  • A study to evaluate the safety of dazodalibep in patients with Sjögren’s Syndrome over a long period of time

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Denmark France Germany Greece +6

powered by